Biotech Values

[Cactus Quave]

You’re effectively asking whether the Court would grant a temporary restraining order to be followed by a preliminary injunction.

If that is the terminology, yes, and I have no idea of the odds of that happening. If the FDA approves TEVA's generic Lovenox, and if the Court does not stop them, TEVA would be free to launch and dramatically impact MNTA's cash flow, though at considerable risk if the Court later rules in MNTA's favor. Given MNTA conservative position in managing cash, and accepting that no one has a crystal ball regarding the FDA, the Court or TEVA, it strikes me that MNTA raising cash, even at a less than ideal share price, is a prudent action.